{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:55:13Z","timestamp":1791258913174,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-037316"],"award-info":[{"award-number":["INV-037316"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-035751"],"award-info":[{"award-number":["INV-035751"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI089674"],"award-info":[{"award-number":["U19AI089674"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI075045"],"award-info":[{"award-number":["R01AI075045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI138496"],"award-info":[{"award-number":["K23AI138496"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Molecular surveillance of drug-resistant\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      is crucial for malaria control in endemic regions. Two targeted-resequencing tools, the Molecular Inversion Probe (MIP) drug resistance panel DR23K and the Multiplexed Amplicons for Drugs, Diagnostics, Diversity, and Differentiation using High-Throughput Targeted Resequencing (MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR) panel, are widely used to detect resistance genotypes. However, comparisons of their performance for genotyping drug resistance polymorphisms in malaria parasites and their comparative utility for other use cases is lacking.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To compare the performance of DR23K and MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR in terms of sequencing depth, sensitivity to minor alleles, and precision, each platform was used to evaluate SNP alleles and microhaplotypes in double- and triple-strain mixtures of well-characterized laboratory parasites at densities of 10, 100, 1000, and 10,000 parasites\/\u03bcL. In addition, 67 Ugandan field samples collected in 2022 were genotyped using each platform to assess performance and concordance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across the four parasite densities of 10, 100, 1000, and 10,000 parasites\/\u03bcL, MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR exhibited superior sequencing depth (mean reads per locus: 144, 992, 1153, and 1300) compared to DR23K (mean unique molecular identifiers [UMIs] per locus: 1, 4, 49, and 364). For SNP detection, MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR achieved 100% sensitivity at 2% within-sample allele frequency (WSAF) at 1000 and 10,000 parasites\/\u03bcL, whereas DR23K achieved 100% sensitivity at 40% and 5% WSAF at these densities, respectively. Microhaplotype sensitivity was lower for both assays; MAD4HatTeR reached 69% sensitivity at 10 parasites\/\u03bcL when WSAF was\u2009\u2265\u200910%, increasing to 100% sensitivity at 2% WSAF and 100 parasites\/\u03bcL. DR23K had\u2009&lt;\u200950% sensitivity at 10 and 100 parasites\/\u03bcL. In field samples, which commonly contain polyclonal infections, high concordance was observed between the two methods for all SNPs (94%, 1848\/1969) and polymorphic SNPs (88%, 898\/1019). All discrepancies were attributed to varied detection of minority alleles in mixed genotype infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR demonstrated higher sensitivity than DR23K, particularly at low parasite densities. Both assays showed strong concordance for genotyping key resistance mutations in field samples, supporting their reliability. These findings suggest MAD\n                      <jats:sup>4<\/jats:sup>\n                      HatTeR as the preferred assay for low-density parasite studies and microhaplotype analysis, while DR23K may be appropriate for specific applications with high-parasite density samples, where detection of minority alleles is not prioritized, or when more comprehensive genome coverage is required.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-025-05441-3","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:25:46Z","timestamp":1749727546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Performance of molecular inversion probe DR23K and Paragon MAD4HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Thomas","family":"Katairo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Asua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bienvenu","family":"Nsengimaana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tukwasibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis D.","family":"Semakuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Wiringilimaana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Kagurusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mwubaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Nakasaanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeya","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahiid","family":"Kiyaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mbabazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisakye D.","family":"Kabbale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisen","family":"Ayitewala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Aranda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"5441_CR1","first-page":"2024","volume-title":"Addressing Inequity in the Global Malaria Response","author":"WHO. World Malaria Report","year":"2024","unstructured":"WHO. World Malaria Report. Addressing Inequity in the Global Malaria Response. Geneva: World Health Organization; 2024. p. 2024."},{"key":"5441_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pt.2023.11.006","volume":"40","author":"S Ruybal-Pes\u00e1ntez","year":"2024","unstructured":"Ruybal-Pes\u00e1ntez S, McCann K, Vibin J, Siegel S, Auburn S, Barry AE. Molecular markers for malaria genetic epidemiology: progress and pitfalls. Trends Parasitol. 2024;40:147\u201363.","journal-title":"Trends Parasitol"},{"key":"5441_CR3","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43510","volume":"8","author":"S Tessema","year":"2019","unstructured":"Tessema S, Wesolowski A, Chen A, Murphy M, Wilheim J, Mupiri A-R, et al. Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa. Elife. 2019;8: e43510.","journal-title":"Elife"},{"key":"5441_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204347","volume":"13","author":"C Nsanzabana","year":"2018","unstructured":"Nsanzabana C, Ariey F, Beck H-P, Ding XC, Kamau E, Krishna S, et al. Molecular assays for antimalarial drug resistance surveillance: a target product profile. PLoS ONE. 2018;13: e0204347.","journal-title":"PLoS ONE"},{"key":"5441_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012194","volume":"20","author":"Y-A Chen","year":"2024","unstructured":"Chen Y-A, Vickers EN, Aranda-Diaz A, Murphy M, Gerlovina I, Rerolle F, et al. Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR. PLoS Pathog. 2024;20: e1012194.","journal-title":"PLoS Pathog"},{"key":"5441_CR6","doi-asserted-by":"crossref","unstructured":"Chen Y-A, Ng P-Y, Garcia D, Elliot A, Palmer B, Assun\u00e7\u00e3o Carvalho RMC d\u2019, et al. Genetic surveillance reveals low, sustained malaria transmission with clonal replacement in Sao Tome and Principe. medRxiv. (preprint). 2024.","DOI":"10.1101\/2024.07.15.24309968"},{"key":"5441_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722\u201332.","journal-title":"N Engl J Med"},{"key":"5441_CR8","doi-asserted-by":"publisher","first-page":"94655","DOI":"10.1093\/infdis\/jiy223","volume":"218","author":"O Aydemir","year":"2018","unstructured":"Aydemir O, Janko M, Hathaway NJ, Verity R, Mwandagalirwa MK, Tshefu AK, et al. Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes. J Infect Dis. 2018;218:94655.","journal-title":"J Infect Dis"},{"key":"5441_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023;8:1911\u20139.","journal-title":"Nat Microbiol"},{"key":"5441_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/infdis\/jis709","volume":"207","author":"A Ouattara","year":"2013","unstructured":"Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, et al. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J Infect Dis. 2013;207:511\u20139.","journal-title":"J Infect Dis"},{"key":"5441_CR11","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","volume":"373","author":"DE Neafsey","year":"2015","unstructured":"Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, et al. Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine. N Engl J Med. 2015;373:2025\u201337.","journal-title":"N Engl J Med"},{"key":"5441_CR12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10: e62997.","journal-title":"Elife"},{"key":"5441_CR13","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4621","volume":"13","author":"JH Kattenberg","year":"2023","unstructured":"Kattenberg JH, Van Dijk NJ, Fern\u00e1ndez-Mi\u00f1ope CA, Guetens P, Mutsaers M, Gamboa D, et al. Molecular surveillance of malaria using the PF AmpliSeq custom assay for Plasmodium falciparum parasites from dried blood spot DNA isolates from Peru. Bio Protoc. 2023;13: e4621.","journal-title":"Bio Protoc"},{"key":"5441_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1534\/genetics.119.302120","volume":"212","author":"AR Taylor","year":"2019","unstructured":"Taylor AR, Jacob PE, Neafsey DE, Buckee CO. Estimating relatedness between malaria parasites. Genetics. 2019;212:1337\u201351.","journal-title":"Genetics"},{"key":"5441_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jiaa527","volume":"225","author":"SK Tessema","year":"2022","unstructured":"Tessema SK, Hathaway NJ, Teyssier NB, Murphy M, Chen A, Aydemir O, et al. Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome. J Infect Dis. 2022;225:1227\u201337.","journal-title":"J Infect Dis"},{"key":"5441_CR16","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1111\/1755-0998.13622","volume":"22","author":"E La Verriere","year":"2022","unstructured":"La Verriere E, Schwabl P, Carrasquilla M, Taylor AR, Johnson ZM, Shieh M, et al. Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: a malaria case study. Mol Ecol Resour. 2022;22:2285\u2013303.","journal-title":"Mol Ecol Resour"},{"key":"5441_CR17","doi-asserted-by":"crossref","unstructured":"de Cesare M, Mwenda M, Jeffreys AE, Chirwa J, Drakeley C, Schneider K, et al. Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing. bioRxiv. (preprint). 2023.","DOI":"10.1101\/2023.02.06.527333"},{"key":"5441_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002743","volume":"4","author":"A Holzschuh","year":"2024","unstructured":"Holzschuh A, Lerch A, Fakih BS, Aliy SM, Ali MH, Ali MA, et al. Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: a feasibility study. PLoS Glob Public Health. 2024;4: e0002743.","journal-title":"PLoS Glob Public Health"},{"key":"5441_CR19","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1038\/s41598-025-94716-5","volume":"15","author":"A Aranda-D\u00edaz","year":"2025","unstructured":"Aranda-D\u00edaz A, Neubauer Vickers E, Murie K, Palmer B, Hathaway N, Gerlovina I, et al. Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health. Sci Rep. 2025;15:10737.","journal-title":"Sci Rep"},{"key":"5441_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1101\/gr.3185605","volume":"15","author":"P Hardenbol","year":"2005","unstructured":"Hardenbol P, Yu F, Belmont J, Mackenzie J, Bruckner C, Brundage T, et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res. 2005;15:269\u201375.","journal-title":"Genome Res"},{"key":"5441_CR21","doi-asserted-by":"publisher","first-page":"e01423","DOI":"10.1128\/AAC.01423-19","volume":"64","author":"BA Mensah","year":"2020","unstructured":"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, et al. Antimalarial drug resistance profiling of Plasmodium falciparum infections in Ghana using molecular inversion probes and next-generation sequencing. Antimicrob Agents Chemother. 2020;64:e01423-e1519.","journal-title":"Antimicrob Agents Chemother"},{"key":"5441_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12: e1001788.","journal-title":"PLoS Med"},{"key":"5441_CR23","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.05141-14","volume":"59","author":"P Tumwebaze","year":"2015","unstructured":"Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, et al. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015;59:3018\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"5441_CR24","doi-asserted-by":"crossref","unstructured":"Aranda-Diaz A, Vickers EN. MAD4HatTeR. 2022 [cited 11 Dec 2024]. Available: https:\/\/www.protocols.io\/view\/mad4hatter-b5gaq3se.pdf","DOI":"10.17504\/protocols.io.14egn779mv5d\/v2"},{"key":"5441_CR25","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13:6353.","journal-title":"Nat Commun"},{"key":"5441_CR26","unstructured":"Hathaway NJ. A suite of computational tools to interrogate sequence data with local haplotype analysis within complex\u200b Plasmodium\u200b infections and other microbial mixtures. Doctoral Dissertation, University of Massachusetts Medical School, 2018. Available: https:\/\/scholar.google.com\/citations?user=st2n6EYAAAAJ&hl=en&num=20&oi=sra"},{"key":"5441_CR27","doi-asserted-by":"crossref","unstructured":"Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, et al. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. medRxiv. (preprint) 2023.","DOI":"10.1101\/2023.11.07.23298207"},{"key":"5441_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41564-021-00962-4","volume":"6","author":"SM Feleke","year":"2021","unstructured":"Feleke SM, Reichert EN, Mohammed H, Brhane BG, Mekete K, Mamo H, et al. Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia. Nat Microbiol. 2021;6:1289\u201399.","journal-title":"Nat Microbiol"},{"key":"5441_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12936-025-05298-6","volume":"24","author":"LN Vanheer","year":"2025","unstructured":"Vanheer LN, Manko E, Mahamar A, Phelan J, Sanogo K, Sinaba Y, et al. Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali. Malar J. 2025;24:111.","journal-title":"Malar J"},{"key":"5441_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/infdis\/jiac169","volume":"226","author":"J Rek","year":"2022","unstructured":"Rek J, Blanken SL, Okoth J, Ayo D, Onyige I, Musasizi E, et al. Asymptomatic school-aged children are important drivers of malaria transmission in a high endemicity setting in Uganda. J Infect Dis. 2022;226:708\u201313.","journal-title":"J Infect Dis"},{"key":"5441_CR31","doi-asserted-by":"crossref","unstructured":"Gaither C, Morgan C, Kirby R, Karema C, Gashema P, White SJ, et al. Prevalence of falciparum and non-falciparum malaria in the 2014\u201315 Rwanda Demographic Health Survey. medRxiv. (preprint). 2024.","DOI":"10.1101\/2024.01.09.24301054"},{"key":"5441_CR32","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120\u20138.","journal-title":"Lancet Infect Dis"},{"key":"5441_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/jiy637","volume":"219","author":"A Yeka","year":"2019","unstructured":"Yeka A, Wallender E, Mulebeke R, Kibuuka A, Kigozi R, Bosco A, et al. Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children. J Infect Dis. 2019;219:1112\u201320.","journal-title":"J Infect Dis"},{"key":"5441_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00153-8","volume":"5","author":"A Schnoz","year":"2024","unstructured":"Schnoz A, Beuret C, Concu M, Hosch S, Rutaihwa LK, Golumbeanu M, et al. Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study. Lancet Microbe. 2024;5: 100914.","journal-title":"Lancet Microbe"},{"key":"5441_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4269\/ajtmh.22-0749","volume":"112","author":"M Golumbeanu","year":"2025","unstructured":"Golumbeanu M, Edi CAV, Hetzel MW, Koepfli C, Nsanzabana C. Bridging the gap from molecular surveillance to programmatic decisions for malaria control and elimination. Am J Trop Med Hyg. 2025;112:35\u201347.","journal-title":"Am J Trop Med Hyg"},{"key":"5441_CR36","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1038\/s41591-023-02641-9","volume":"29","author":"T Emiru","year":"2023","unstructured":"Emiru T, Getachew D, Murphy M, Sedda L, Ejigu LA, Bulto MG, et al. Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa. Nat Med. 2023;29:3203\u201311.","journal-title":"Nat Med"},{"key":"5441_CR37","doi-asserted-by":"crossref","unstructured":"Boene S, Rovira-Vallbona E, da Silva C, Garc\u00eda-Ulloa M, Rafael B, Canana N, et al. Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities (2021\u20132022). VeriiXiv. (preprint). 2024.","DOI":"10.12688\/verixiv.444.1"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05441-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:25:48Z","timestamp":1749727548000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5441"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05441-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5743980\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of relevant Ethical Committee Reivew. All study participants provided informed consent for sample collection and for future use of biological specimens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}